Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mehta

Showing results (1031-1040 of 1,815) with videos related to

Pageof 182
Sort By:
Blood|February 28, 2020
Association of clinical severity with FANCB variant type in Fanconi anemiaMoonjung Jung, Ramanagouda Ramanagoudr-Bhojappa, Sylvie van Twest, et al.
Frontiers in Psychiatry|November 19, 2025
Differential effects of a single dose of Lisdexamfetamine and Guanfacine on cognitive function in children with ADHDSahid El Masri, Olivia S Kowalczyk, Tsz Hei Chiu, et al.
Journal of Inherited Metabolic Disease|November 8, 2003
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statementT M Cox, J M F G Aerts, G Andria, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 7, 2026
Aetiological factors in functional seizures and functional motor symptoms: shared and distinct featuresL S Merritt Millman, Snigdha Bhuma, Yasmine Basamh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Journal of Virology|May 25, 2012
The fanconi anemia pathway limits human papillomavirus replicationElizabeth E Hoskins, Richard J Morreale, Stephen P Werner, et al.
Vaccine|March 3, 2018
Immunization education for internal medicine residents: A cluster-randomized controlled trialJennifer A Whitaker, Caroline M Poland, Thomas J Beckman, et al.
Nature Communications|January 27, 2022
Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinationsMiriam Vignando, Dominic Ffytche, Simon J G Lewis, et al.
Psychological Medicine|March 3, 2026
Cognition and metacognition in functional motor symptoms and functional seizures: a case-control studySusannah Pick, L S Merritt Millman, Esin Gun Gürsoy, et al.
The Pharmacogenomics Journal|August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanesC F Spraggs, L R Parham, L P Briley, et al.
Pageof 182

Showing results (1031-1040 of 1,815) with videos related to

Sort By:
Pageof 182
Blood|February 28, 2020
Association of clinical severity with FANCB variant type in Fanconi anemiaMoonjung Jung, Ramanagouda Ramanagoudr-Bhojappa, Sylvie van Twest, et al.
Frontiers in Psychiatry|November 19, 2025
Differential effects of a single dose of Lisdexamfetamine and Guanfacine on cognitive function in children with ADHDSahid El Masri, Olivia S Kowalczyk, Tsz Hei Chiu, et al.
Journal of Inherited Metabolic Disease|November 8, 2003
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statementT M Cox, J M F G Aerts, G Andria, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 7, 2026
Aetiological factors in functional seizures and functional motor symptoms: shared and distinct featuresL S Merritt Millman, Snigdha Bhuma, Yasmine Basamh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Journal of Virology|May 25, 2012
The fanconi anemia pathway limits human papillomavirus replicationElizabeth E Hoskins, Richard J Morreale, Stephen P Werner, et al.
Vaccine|March 3, 2018
Immunization education for internal medicine residents: A cluster-randomized controlled trialJennifer A Whitaker, Caroline M Poland, Thomas J Beckman, et al.
Nature Communications|January 27, 2022
Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinationsMiriam Vignando, Dominic Ffytche, Simon J G Lewis, et al.
Psychological Medicine|March 3, 2026
Cognition and metacognition in functional motor symptoms and functional seizures: a case-control studySusannah Pick, L S Merritt Millman, Esin Gun Gürsoy, et al.
The Pharmacogenomics Journal|August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanesC F Spraggs, L R Parham, L P Briley, et al.
Pageof 182